Table 1.
Pretransplant Demographics of 155 Patients with HCC Who Underwent LT
| Pretransplant Criteria | N = 155 | p Value |
|---|---|---|
| Median age (range) | 57 (28–70) | 0.48 |
| Sex | 0.38 | |
| Male | 123 (79%) | |
| Female | 32 (21%) | |
| Cause of liver disease | 0.10 | |
| HCV | 79 (51%) | |
| HBV | 25 (16%) | |
| Alcohol | 34 (22%) | |
| Cryptogenic | 7 (4.5%) | |
| Alpha-1 antitrypsin | 6 (3.9%) | |
| NASH | 2 (1.3%) | |
| PBC | 2 (1.3%) | |
| Pretransplant therapy | 0.67 | |
| Ablation | 36 (23%) | |
| Resection | 6 (3.9%) | |
| TACE | 1 (0.6%) | |
| EBRT | 1 (0.6%) | |
| None | 111 (72%) |
The p values were determined by log-rank test as predictor of DFS after Kaplan–Meier analysis.
NASH = nonalcoholic steatohepatitis, PBC = primary biliary cirrhosis, EBRT = external beam radiation therapy